Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
J Am Soc Nephrol ; 15(2): 493-500, 2004 Feb.
Article in English | MEDLINE | ID: mdl-14747398

ABSTRACT

Autosomal dominant polycystic kidney disease (ADPKD) is characterized by exuberant inflammation and fibrosis, a process believed to contribute to progressive loss of normal renal function. Despite early-onset hypertension and intrarenal renin/angiotensin II (AngII) activation, angiotensin-converting enzyme (ACE) inhibition does not consistently confer renal protection in ADPKD. The hypothesis was that mast cells within the inflammatory interstitium release chymase, an enzyme capable of efficient conversion of AngI to AngII, providing an ACE-independent route of AngII generation. End-stage ADPKD renal tissue extracts and cyst fluids were assayed for time-dependent, chymostatin-inhibitable conversion of (125)I-AngI to (125)I-AngII under conditions of ACE and aminopeptidase inhibition by means of HPLC. Thirteen of 14 ADPKD kidney extracts exhibited chymase-like AngII-generating capacity; calculated initial reaction rates averaged 3.9 +/- 2.9 fmol AngII/min/ micro g protein with a mean maximal conversion of 55% +/- 30% of added substrate. AngII-generating activity was both protein and substrate dependent. All five cyst fluid samples were negative. Chymase-like activity was detectable in only three of six non-ADPKD kidney extracts. Immunoreactive chymase protein was present in/around mast cells within the fibrotic renal interstitium in all samples. Findings demonstrate for the first time the presence of mast cells, mast cell-associated immunoreactive chymase protein, and chymase-like AngII generating capacity in ADPKD cystic kidneys. Results support the potential for ACE-independent AngII generation and for mast cell-initiated inflammatory processes in ADPKD, each with therapeutic implications for ADPKD renal progression.


Subject(s)
Angiotensin II/metabolism , Polycystic Kidney, Autosomal Dominant/enzymology , Serine Endopeptidases/metabolism , Chymases , Humans , Kidney/immunology , Kidney/metabolism , Serine Endopeptidases/immunology
2.
J Mol Biol ; 331(1): 155-65, 2003 Aug 01.
Article in English | MEDLINE | ID: mdl-12875842

ABSTRACT

The yeast ATM1 gene is essential for normal cellular iron homeostasis. Deletion of ATM1 results in mitochondrial iron accumulation and increased sensitivity to oxidative stress and transition metal toxicity. Atm1p is an ATP-binding cassette (ABC) transporter localized to the mitochondrial inner membrane. The specific function of Atm1p has not been determined, though roles in both mitochondrial iron export and cytosolic Fe-S cluster assembly have been proposed. We undertook a screen for yeast genes capable of suppressing the abnormalities of cellular iron metabolism demonstrated by Deltaatm1 cells. One of the genes we identified was MDL1, which like ATM1, encodes a mitochondrial inner membrane ABC transporter. Mdl1p has previously been shown to function in the export of peptides from the mitochondrial matrix. We demonstrate that over-expression of MDL1 in Deltaatm1 cells results in a reduction of mitochondrial iron content, and decreased sensitivity to H(2)O(2) and transition metal toxicity. Additionally, in studies of the effect of over-expression and deletion of MDL1, we have identified a novel role for Mdl1p in the regulation of cellular resistance to oxidative stress.


Subject(s)
ATP-Binding Cassette Transporters/antagonists & inhibitors , ATP-Binding Cassette Transporters/physiology , Oxidative Stress , Saccharomyces cerevisiae Proteins/antagonists & inhibitors , Amino Acid Sequence , Conserved Sequence , Hydrogen Peroxide/pharmacology , Iron/analysis , Mitochondria/chemistry , Mitochondria/metabolism , Mitochondrial Proteins/physiology , Molecular Sequence Data , Saccharomyces cerevisiae/drug effects , Saccharomyces cerevisiae/growth & development , Saccharomyces cerevisiae/metabolism , Saccharomyces cerevisiae Proteins/physiology , Transition Elements/pharmacology
3.
Am J Physiol Renal Physiol ; 283(4): F755-64, 2002 Oct.
Article in English | MEDLINE | ID: mdl-12217867

ABSTRACT

To identify an appropriate model of human renin-angiotensin system (RAS) involvement in fetal origins of adult disease, we quantitated renal ANG II AT(1) and AT(2) receptors (AT1R and AT2R, respectively) in fetal (90-day gestation, n = 14), neonatal (3-wk, n = 5), and adult (6-mo, n = 8) microswine by autoradiography ((125)I-labeled [Sar(1)Ile(8)]ANG II+cold CGP-42112 for AT1R, (125)I-CGP-42112 for AT2R) and by whole kidney radioligand binding. The developmental pattern of renal AT1R in microswine, like many species, exhibited a 10-fold increase postnatally (P < 0.001), with maximal postnatal density in glomeruli and lower density AT1R in extraglomerular cortical and outer medullary sites. With aging, postnatal AT1R glomerular profiles increased in size (P < 0.001) and fractional area occupied (P < 0.04), with no change in the number per unit area. Cortical levels of AT2R by autoradiography fell with age from congruent with 5,000 fmol/g in fetal kidneys to congruent with 60 and 20% of fetal levels in neonatal and adult cortex, respectively (P < 0.0001). The pattern of AT2R binding in postnatal pig kidney mimicked that described in human and simian, but not rodent, species: dense AT2R confined to discrete cortical structures, including pre- and juxtaglomerular, but not intraglomerular, vasculature. Our results provide a quantitative assessment of ANG II receptors in developing pig kidney and document the concordance of pigs and primates in developmental regulation of renal AT1R and AT2R.


Subject(s)
Angiotensin II/metabolism , Kidney/growth & development , Kidney/metabolism , Receptors, Angiotensin/metabolism , Animals , Animals, Newborn , Autoradiography , Female , Image Processing, Computer-Assisted , In Vitro Techniques , Kidney/embryology , Membranes/metabolism , Pregnancy , Radioligand Assay , Receptor, Angiotensin, Type 1 , Receptor, Angiotensin, Type 2 , Swine , Swine, Miniature
4.
Arterioscler Thromb Vasc Biol ; 22(7): 1113-21, 2002 Jul 01.
Article in English | MEDLINE | ID: mdl-12117725

ABSTRACT

OBJECTIVE: To identify vascular cells capable of responding to angiotensin II (Ang II) generated in conduit arteries, we examined the Ang II type 1 receptor (AT1R) and Ang II type 2 receptor (AT2R) in the thoracic aorta (TA) and abdominal aorta (AA) and branches in 90-day fetal, 3-week postnatal, and 6-month adult microswine. METHODS AND RESULTS: By autoradiography ((125)I-[Sar(1)Ile(8)]-Ang II with or without AT1R- or AT2R-selective analogues or (125)I-CGP 42112), there were striking rostrocaudal differences in (1) AT2R binding at all ages (prominent in AA wall and branches, sparse in TA wall and branches) and (2) a non-AT2R binding site for CGP 42112 (consistently evident in postnatal TA and branches but absent in AA and branches). Furthermore, patterns of AT2R distribution in infradiaphragmatic arteries were developmentally distinct. In fetal AAs, high-density AT2Rs occupied the inner 60% of the medial-endothelial wall. In postnatal AAs, AT2Rs were sparse in the medial-endothelial wall but prominent in a circumferential smooth muscle alpha-actin-negative cell layer at the medial-adventitial border, occupying approximately 20% to 25% of the AA cross-sectional area. AT1R density in the TA and AA medial-endothelial wall increased with age, whereas AT2R density decreased after birth. CONCLUSIONS: A novel AT2R-positive cell layer confined to postnatal infradiaphragmatic arteries physically links adventitial and medial layers, appears optimally positioned to transduce AT2R-dependent functions of local Ang II, and suggests that adventitial Ang II may elicit regionally distinct vascular responses.


Subject(s)
Aorta, Abdominal/chemistry , Aorta, Abdominal/metabolism , Aorta, Thoracic/chemistry , Aorta, Thoracic/metabolism , Receptors, Angiotensin/metabolism , Actins/metabolism , Angiotensin II/antagonists & inhibitors , Angiotensin II/metabolism , Angiotensin II Type 1 Receptor Blockers , Angiotensin II Type 2 Receptor Blockers , Angiotensin Receptor Antagonists , Animals , Animals, Newborn/blood , Aorta, Abdominal/physiology , Aorta, Thoracic/physiology , Autoradiography , Binding Sites , Fetus/blood supply , Iodine Radioisotopes/analysis , Membranes/chemistry , Membranes/metabolism , Muscle, Smooth/chemistry , Muscle, Smooth/embryology , Muscle, Smooth/metabolism , Oligopeptides/analysis , Radioligand Assay , Receptor, Angiotensin, Type 1 , Receptor, Angiotensin, Type 2 , Swine , Swine, Miniature/blood , Swine, Miniature/embryology , Tunica Media/chemistry , Tunica Media/embryology , Tunica Media/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...